Powder: -20°C for 3 years | In solvent: -80°C for 1 year
HTH-01-091 is a potent and selective maternal embryonic leucine zipper kinase (MELK) inhibitor (IC50: 10.5 nM).HTH-01-091 inhibits PIM1/2/3, RIPK2, DYRK3, smMLCK and CLK2. HTH-01-091 can be used to study breast cancer.
パッケージサイズ | 在庫状況 | 単価(税別) |
---|---|---|
1 mg | 在庫あり | ¥ 80,500 |
5 mg | 在庫あり | ¥ 190,000 |
10 mg | 在庫あり | ¥ 259,500 |
25 mg | 在庫あり | ¥ 365,000 |
50 mg | 在庫あり | ¥ 454,500 |
100 mg | 在庫あり | ¥ 574,000 |
500 mg | 在庫あり | ¥ 1,124,500 |
1 mL * 10 mM (in DMSO) | 在庫あり | ¥ 189,000 |
説明 | HTH-01-091 is a potent and selective maternal embryonic leucine zipper kinase (MELK) inhibitor (IC50: 10.5 nM).HTH-01-091 inhibits PIM1/2/3, RIPK2, DYRK3, smMLCK and CLK2. HTH-01-091 can be used to study breast cancer. |
ターゲット&IC50 | mTOR:632 nM, CDK7:1230 nM, DYRK4:41.8 nM, Pim1:60.6 nM |
In vitro |
HTH-01-091 (0-10 μM, 1 h) dose-dependently decreased MELK pull-down by streptavidin beads, demonstrating that the compound is cell permeable and binds to MELK in an ATP-competitive fashion causes MELK degradation.[1] HTH-01-091 (1 μM) selectively inhibits 4% of the kinases over 90%[1]. HTH-01-091 (0-10 μM, 3 days) exhibits minor antiproliferative effects in breast cancer cells[1]. |
別名 | HTH-01091, HTH01-091, HTH 01-091, HTH 01091 |
分子量 | 499.43 |
分子式 | C26H28Cl2N4O2 |
CAS No. | 2000209-42-5 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 5 mg/mL (10 mM)
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
HTH-01-091 2000209-42-5 Apoptosis Cell Cycle/Checkpoint Chromatin/Epigenetic JAK/STAT signaling Metabolism NF-Κb PI3K/Akt/mTOR signaling Tyrosine Kinase/Adaptors CDK RIP kinase Serine/threonin kinase DYRK Pim MELK HTH01091 HTH-01091 HTH01-091 HTH 01-091 HTH 01091 Inhibitor inhibitor inhibit